Skip to content
value.today
Catalyst Biosciences logo

Catalyst Biosciences

CBIO
$637 Mmarket cap on Aug 1, 2026
Compare
World rank
#11,516
Revenue
$117 M
For year ending December-2025
value.today research
Net income
$10 M
8.5% margin
value.today research
Employees
—

Catalyst Biosciences in brief

Catalyst Biosciences is a listed company in the Biotechnology industry, based in the USA. Its market value was $637 M on 1 August 2026, which makes it the 11,516th largest listed company in the world and the 2,381st largest in the USA on this site. In the year to December 2025 it had sales of $117 M and a net profit of $10 M, about 8 cents of profit for every dollar of sales. Its shares trade under the symbol CBIO (Nasdaq).

Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.

Market cap history

$0 M$172 M$344 M$516 M$688 M2020202120222023202420252026

World rank over time

▲ up 8,589 places since 2020
2020-01-01: #19885#19,88520202021-01-01: #16926#16,92620212022-01-07: #28676#28,67620222022-12-25: #30366#30,36620222023-07-30: #30617#30,61720232026-03-08: #8123#8,12320262026-08-01: #11296#11,2962026

Rank in USA: #3,854 (Jan 2020) · #3,487 (Jan 2021) · #5,258 (Jan 2022) · #5,407 (Dec 2022) · #5,319 (Jul 2023) · #1,456 (Mar 2026) · #2,379 (Aug 2026)

Key ratios

market cap and latest results
P/E ratio
64.5×
Price / sales
5.5×
Price / book
4.5×
Free cash flow yield
—
Net margin
8.5%
Operating margin
9.9%
Return on equity
6.9%
Liabilities / assets
14.4%

Annual results

Revenue
$117 M
Operating income
$11 M
Net income
$10 M

For year ending December-2025

Balance sheet

Total assets
$166 M
Total liabilities
$24 M
Total equity
$142 M

As of December-2025

Top 24 institutional investors in Catalyst Biosciences#

As of Sep 30, 2026
24 institutions held 11.1 M shares on Sep 30, 2026. Filings read through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 24 largest institutional investors in Catalyst Biosciences
#InstitutionShares heldChange (shares)ValueFiled
1Adage Capital Partners GP, L.L.C.1,800,000New$18 MNov 16, 2026
2Linden Advisors LP1,300,000New$13 MNov 16, 2026
3Tenor Capital Management Company, L.P.1,000,000New$10 MNov 16, 2026
4Sculptor Capital LP879,997New$9 MNov 13, 2026
5Shaolin Capital Management LLC700,000New$7 MNov 13, 2026
6BNP Paribas Financial Markets681,794New$7 MNov 12, 2026
7Polar Asset Management Partners Inc.600,000New$6 MNov 16, 2026
8Verition Fund Management LLC557,664New$5 MNov 13, 2026
9HBK Investments L P400,000New$4 MNov 16, 2026
10Radcliffe Capital Management, L.P.400,000New$4 MNov 16, 2026
11Two Sigma Investments, LP362,500New$4 MNov 16, 2026
12Picton Mahoney Asset Management350,000New$3 MNov 9, 2026
13Whitebox Advisors LLC325,000New$3 MNov 16, 2026
14Berkley W R Corp321,691New$3 MNov 16, 2026
15Hudson Bay Capital Management LP300,000New$3 MNov 13, 2026
16O'Connor Alternative Investments, LLC300,000New$3 MNov 16, 2026
17Ghisallo Capital Management LLC200,000New$2 MNov 16, 2026
18Clear Street Group Inc.158,771New$2 MNov 16, 2026
19Jpmorgan Chase & Co140,260New$1 MNov 12, 2026
20K2 Principal Fund, L.P.109,902New$1 MNov 13, 2026
21Toronto Dominion Bank100,000New$1 MNov 16, 2026
22Virtu Financial LLC43,896New$0 MNov 17, 2026
23Deltec Asset Management LLC30,000New$0 MOct 26, 2026
24UBS Group AG5New$0 MNov 10, 2026

Discuss Catalyst Biosciences#

0 automatic updates and 0 member comments. Sign in to comment and react.

No posts yet. Write the first comment.

How Catalyst Biosciences compares in Biotechnology

  • Market cap$637 M · higher than 61% of 729
  • Revenue$117 M · higher than 70% of 648
  • Net margin8.5% · higher than 76% of 408
  • P/E ratio64.5× · lower than 16% of 100
  • Price / sales5.5× · lower than 60% of 340
  • Price / book4.5× · lower than 34% of 535

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Catalyst Biosciences🇺🇸$637 M64.5×8.5%—
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

How current the figures are

Market cap:
Aug 1, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 22, 2026

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Catalyst Biosciences? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Catalyst Biosciences's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Catalyst Biosciences? Suggest a correction